Search Results for "Skin"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Skin. Results 31 to 40 of 438 total matches.
Linezolid (Zyvox)
The Medical Letter on Drugs and Therapeutics • May 29, 2000 (Issue 1079)
-susceptible Streptococcus pneumoniae, and skin and skin structure infections, including those due ...
Linezolid, the first of a new class of antibiotics, the oxazolidinones, has been marketed for treatment of infection due to vancomycin-resistant Enterococcus faecium, nosocomial and community-acquired pueumonia due to Staphylococcus aureus or penicillin-sucsceptible Streptococcus pneumoniae, and skin and skin structure infections, including those due to methicillin-resistant S. aureus (MRSA).
A New Sunscreen Agent
The Medical Letter on Drugs and Therapeutics • May 20, 2007 (Issue 1261)
) RADIATION — Solar UV radiation capable of injuring the skin is classified by wavelength into UVA1 (340-400 ...
Ecamsule (terephthalylidene dicamphor sulfonic acid), the first new sunscreen agent to be approved by the FDA in 18 years, is now available in the US in a moisturizer called Anthelios SX. Ecamsule has been used in Canada and Europe for more than 10 years.
Shade UVAGuard - A Second Broad-Spectrum Sunscreen
The Medical Letter on Drugs and Therapeutics • Jun 11, 1993 (Issue 898)
) is
the major cause of sunburn and chronic skin injury, including photoaging and skin cancer, and contributes ...
In 1989, Photoplex (Allergan Herbert), a combination of the dibenzoyl methane avobenzone (Parsol 1789) and the aminobenzoic acid (PABA) ester padimate O, was the first 'broad spectrum' sunscreen to become available in the USA (Medical Letter, 31:59, 1989). Now, Shade UVAGuard (Schering-Plough), a similar product, has been approved by the US Food and Drug Administration; it also contains avobenzone, plus the benzophenone oxybenzone and octyl methoxycinnamate.
Tigecycline (Tygacil)
The Medical Letter on Drugs and Therapeutics • Sep 12, 2005 (Issue 1217)
and skin and
skin-structure infections. It is the first of a new class of
antibiotics called ...
Tigecycline (Tygacil - Wyeth), a derivative of minocycline, is a new intravenous (IV) antibiotic approved for treatment of complicated intra-abdominal and skin and skin-structure infections.
Quinupristin/Dalfopristin
The Medical Letter on Drugs and Therapeutics • Nov 19, 1999 (Issue 1066)
by vancomycinresistant Enterococcus faecium (VREF), and for treatment of complicated skin and skin structure infections ...
Quinupristin and dalfopristin, two streptogramin antibacterials marketed in a 30:70 combination as Synercid, have received accelerated approval from the FDA for intravenous treatment of bacteremia and life-threatening infection....
Tattoo Removal
The Medical Letter on Drugs and Therapeutics • Nov 24, 2003 (Issue 1170)
removal of all pigments with restoration of normal skin color and texture is not always possible (M ...
While more people than ever are getting tattoos, many come to regret their decision and would like to have them removed. The technology of removing tattoos is much better than it used to be, but still far from perfect. Complete removal of all pigments with restoration of normal skin color and texture is not always possible (M Kuperman-Beade et al, Am J Clin Dermatol 2001; 2:21; GM Lipper and RR Anderson in IM Freedberg et al, eds, Fitzpatrick's Dermatology in General Medicine 6th ed, New York:McGraw-Hill 2003, page 2508).
Testosterone Topical Solution (Axiron) for Hypogonadism
The Medical Letter on Drugs and Therapeutics • Jul 11, 2011 (Issue 1368)
of
hypogonadism at baseline or after treatment.
ADVERSE EFFECTS — Skin reactions at the site of
application ...
The Medical Letter recently reviewed a topical gel formulation
of testosterone (Fortesta) for treatment of
hypogonadism in men. A topical testosterone replacement
product for application to the axilla, Axiron (Lilly)
solution, has now become available for the same indication.
This site of application presumably minimizes
the risk of transferring the drug to a family member or
sexual partner.
Calcipotriene for Psoriasis
The Medical Letter on Drugs and Therapeutics • Aug 05, 1994 (Issue 928)
sheets and clothing
as well as skin. Resistant disease can be controlled with photochemotherapy (PUVA ...
Calcipotriene ointment 0.005% (calcipotriol; Dovonex - Westwood Squibb), a synthetic vitamin D 3 analog previously available in Europe and Canada, has now been approved by the US Food and Drug Administration (FDA) for treatment of moderate plaque psoriasis, the most common form of the disease.
Drugs for Common Bacterial Infections in Adults
The Medical Letter on Drugs and Therapeutics • Oct 23, 2017 (Issue 1532)
respiratory, skin, and
urinary tract infections are listed in Tables 1-3. Infectious
disease experts now ...
Bacterial infections in adults are generally treated
empirically, with the antibiotic covering most, but not
all, of the potential causative pathogens. For some
infections, culture and sensitivity testing can guide
treatment, allowing for use of narrower-spectrum
antibiotics. The recommended dosages and durations
of antibiotic treatment for common respiratory, skin, and
urinary tract infections are listed in Tables 1-3. Infectious
disease experts now recommend shorter treatment
durations for many infections to reduce the development
of antimicrobial resistance and minimize adverse...
Ingenol Mebutate (Picato) for Actinic Keratoses
The Medical Letter on Drugs and Therapeutics • Apr 30, 2012 (Issue 1389)
of the Euphorbia
peplus plant, a traditional folk remedy for warts and
other skin lesions.
ACTINIC KERATOSES ...
The FDA has approved ingenol mebutate (Picato –
Leo) for topical treatment of actinic keratoses (AKs).
The new drug is derived from the sap of the Euphorbia
peplus plant, a traditional folk remedy for warts and
other skin lesions.